Cancer Diagnostics

Selected news for the healthcare topic - Cancer Diagnostics, collected since 10/2017. This healthcare topic shares news with Prostate Cancer, COVID-19, Siemens, Genomic Health, Digital Pathology and over a hundred others.

Please provide a valid email address.
Shares Healthcare News With (link):
Healthcare Topics Prostate Cancer, COVID-19, Digital Pathology, Oncology, Infectious Disease, Biotech, Medical Analytics, Genomics, Diagnostic Tests, Precision Medicine, Companion Diagnostics, Food and Drug Administration, Molecular Diagnostics, Precision Oncology, Medical Imaging, Dermatology, Clinical Validation, Diabetes Management, Medicare, Clinical Research, National Cancer Institute
Companies Siemens, Genomic Health, Thermo Fisher, Abbott Laboratories, Ibex Medical Analytics, Exact Sciences, Thermo Fisher Scientific, Roche Diagnostics, Illumina, GE Healthcare, Siemens Healthcare, Pfizer, Leica Biosystems, Quest Diagnostics, Qiagen, Myriad Genetics, Siemens Healthineers, Oncotype, Biodesix, Merck, Novartis, Guardant Health, Cernostics
People Derek Maetzold, Kevin Conroy, Laura Wood
Locations State of Texas, State of New York, New York, New York

Selected Headlines

Date Headline (link) Source Relevant Snippet
10/19/2021 HLTH21: Roche, Ibex Medical Partner to Develop AI-Powered Digital Pathology Apps HIT Consultant What You Should Know: Ibex Medical Analytics , the pioneer in AI-based cancer diagnostics , today announced that it has signed a deal with Roche , the world’s largest biotech company and global pioneer in pharmaceuticals and diagnostics. Ibex will be integrating its Galen™ platform into Roche’s uPath enterprise cloud software in order to help pathologists to enable pathologists to seamlessly access Ibex’s AI algorithms, insights, and decision ...
10/18/2021 Natera launches lung DNA test for catching transplant rejections FierceBiotech ... shortly after clinical data for the diagnostic was touted earlier this month , as a late-breaking presentation during the annual meeting of the American College of Chest Physicians.RELATED: 'Cell-free' CRISPR could improve cancer diagnostics , unravel how gene editing worksA prospective validation study conducted by The Ohio State University’s lung transplant program compared 204 blood tests with lung tissue biopsy samples, taken from 104 organ recipients. Thirty ...
10/18/2021 Head & Neck Cancer Diagnostics Market Research Report by Diagnostic Method, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19 Globe Newswire New York, Reportlinker.com announces the release of the report "Head & Neck Cancer Diagnostics Market Research Report by Diagnostic Method, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p06175415/?utm_source=GNWThe Global Head & Neck Cancer Diagnostics Market size was estimated at USD 1,103.83 million in 2020 and expected to reach USD 1,283.21 million in 2021, at a CAGR 16.58% to reach ...
10/18/2021 Roche announces collaboration with Ibex Medical Analytics to develop artificial intelligence-based digital pathology applications for improved patient care roboticulized.com Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has entered an agreement with Ibex Medical Analytics, a global leader in artificial intelligence (AI)-based cancer diagnostics . Under the agreement, the companies will jointly develop an embedded image analysis workflow for pathologists to seamlessly access Ibex’s AI algorithms, insights, and decision support tools using NAVIFY Digital Pathology, the cloud version of Roche’s uPath enterprise software. Collaborations with ...
10/18/2021 Roche announces collaboration with Ibex Medical Analytics indiamedtoday.com To develop artificial intelligence-based digital pathology applications for improved patient care Roche has entered an agreement with Ibex Medical Analytics, a global leader in artificial intelligence (AI)-based cancer diagnostics . Under the agreement, the companies will jointly develop an embedded image analysis workflow for pathologists to seamlessly access Ibex’s AI algorithms, insights, and decision support tools using NAVIFY Digital Pathology, the cloud version of Roche’s uPath enterprise ...
10/18/2021 Roche announces collaboration with Ibex Medical Analytics to develop artificial intelligence-based digital pathology applications for improved patient care tncontentexchange.com ... innovation SANTA CLARA, Calif., Oct. 18, 2021 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has entered an agreement with Ibex Medical Analytics, a global leader in artificial intelligence (AI)-based cancer diagnostics . Under the agreement, the companies will jointly develop an embedded image analysis workflow for pathologists to seamlessly access Ibex's AI algorithms, insights, and decision support tools using NAVIFY Digital Pathology, the cloud version of ...
10/18/2021 Roche and Ibex to Collaborate on AI-Based Digital Pathology Applications clpmag.com Roche has entered an agreement with Ibex Medical Analytics, a provider of artificial intelligence (AI)-based cancer diagnostics . Under the agreement, the companies will jointly develop an embedded image analysis workflow for pathologists to seamlessly access Ibex’s AI algorithms, insights, and decision support tools using NAVIFY Digital Pathology, the cloud version of Roche’s uPath enterprise software. Collaborations with AI companies like Ibex are made possible through Roche’s ...
10/17/2021 Cervical Cancer Diagnostics Market 2019 Global Trends, Industry Share, Size, Growth, Opportunities, Revenue and Forecast to 2022 picayunecurrent.com Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of global cervical cancer diagnostics market By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies), By Age Group (Below 35 years and 35 years & above), By Region (North America, Europe, Asia Pacific and Rest of the World) and By Country (U.S, Canada ...
10/16/2021 Blood Cancer Diagnostics Market Top Companies, Business Insights,Growth, Market Size Global Market Share, Global Market Size, Trends, Sales, Revenue, Forecast and Detailed Analysis packagingnews24.com Blood Cancer Diagnostics Market Top Companies, Business Insights,Growth, Market Size Global Market Share, Global Market Size, Trends, Sales, Revenue, Forecast and Detailed Analysis The research study offers deep evaluation of the global Blood Cancer Diagnostics market and helps market participants to gain a strong foothold in the industry. It sheds light on critical market dynamics such as drivers, restraints, trends, and opportunities to help businesses prepare for any challenges ...
10/14/2021 Challenges in Detection of Serum Oncoprotein: Relevance to Breast Cancer Diagnostics dovepress.com Back to Journals » Breast Cancer: Targets and Therapy » Volume 13 Challenges in Detection of Serum Oncoprotein: Relevance to Breast Cancer Diagnostics Authors Lengfeld J , Zhang H , Stoesz S , Murali R , Pass F , [Greene ...
10/13/2021 New California Law Increases Access to Biomarker Testing for Late-Stage Cancer Patients PR Newswire CAMBRIDGE, England Biofidelity, a pioneer in precision cancer diagnostics , today praised California Governor Gavin Newsom and the California legislature for the October 6 th passage of SB 535 , a bill that prohibits health care insurers that already cover biomarker testing from requiring prior authorization for patients with advanced stage cancer."Every patient deserves to have the very best treatment options," says Barnaby Balmforth , PhD, Chief Executive Officer at Biofidelity. "This ...
10/12/2021 Global Liquid Biopsy Markets 2021-2025 - Instruments Key to Market Share & Bioinformatics Plays a Role Globe Newswire ... Cell-Free DNA? Exosomes? Find out about the technology in readily understood terms that explain the jargon. Find the opportunities and pitfalls. Understand growth expectations and the ultimate potential market size. A revolution in cancer diagnostics is occurring using in vitro blood testing to identify cancer DNA. The technology has created the possibility of widespread screening for all types of cancers with a blood test. GRAIL, a new company with ...
10/12/2021 Global Liquid Biopsy Markets 2021-2025 - Instruments Key to Globe Newswire ... Cell-Free DNA? Exosomes? Find out about the technology in readily understood terms that explain the jargon. Find the opportunities and pitfalls. Understand growth expectations and the ultimate potential market size.A revolution in cancer diagnostics is occurring using in vitro blood testing to identify cancer DNA. The technology has created the possibility of widespread screening for all types of cancers with a blood test.GRAIL, a new company with ...
10/12/2021 Liquid Biopsy Markets by Cancer Type and Usage Type with Impact of COVID-19 Pandemic, Q4 2021 Report - ResearchAndMarkets.com Yahoo News ... Cell-Free DNA? Exosomes? Find out about the technology in readily understood terms that explain the jargon. Find the opportunities and pitfalls. Understand growth expectations and the ultimate potential market size.A revolution in cancer diagnostics is occurring using in vitro blood testing to identify cancer DNA. The technology has created the possibility of widespread screening for all types of cancers with a blood test.GRAIL, a new company with ...
10/12/2021 Liquid Biopsy Markets by Cancer Type and Usage Type with Impact of COVID-19 Pandemic, Q4 2021 Report - ResearchAndMarkets.com Business Wire ... Cell-Free DNA? Exosomes? Find out about the technology in readily understood terms that explain the jargon. Find the opportunities and pitfalls. Understand growth expectations and the ultimate potential market size. A revolution in cancer diagnostics is occurring using in vitro blood testing to identify cancer DNA. The technology has created the possibility of widespread screening for all types of cancers with a blood test. GRAIL, a new company with ...
10/12/2021 World Liquid Biopsy Markets Report 2021: Liquid Biopsy Progress Delayed by COVID Pandemic but Huge Cancer Screening Opportunity Still Looms - Forecast to 2025 PR Newswire ... Cell-Free DNA? Exosomes? Find out about the technology in readily understood terms that explain the jargon. Find the opportunities and pitfalls. Understand growth expectations and the ultimate potential market size.A revolution in cancer diagnostics is occurring using in vitro blood testing to identify cancer DNA. The technology has created the possibility of widespread screening for all types of cancers with a blood test.GRAIL, a new company with ...
10/12/2021 Lung Cancer Diagnostics Market Ongoing Investments Suggesting it's Attracting Big Players and Hence Making the Industry Competitive, Key Players – Illumina, Inc., Abbott, Thermo Fisher Scientific, Inc. Wordpress.com New York, United States: The newly launched Lung Cancer Diagnostics Market research report prepared by a group of market researchers at DECISIVE MARKETS INSIGHTS provides an elaborative market business research including deep market knowledge facts and analysis. It is done to ensure that it always reflects the most up-to-date market dynamics and data information in this business industry to its readers. As a result, the conclusive results and ...
10/12/2021 Oesophageal Cancer Diagnostics Market expected to Witness a Sustainable Growth over 2019 – 2029 instanttechnews.com The Oesophageal Cancer Diagnostics Market research report aims to provide an unbiased and a comprehensive outlook of the global market to the readers. Analysts have studied the key trends defining the trajectory of the market. The research report also includes an assessment of the achievements made by the players in the Oesophageal Cancer Diagnostics Market so far. It also notes the key trends in the market that are likely to ...
10/12/2021 Liquid Biopsy Markets by Cancer Type and Usage Type with Impact of COVID-19 Pandemic, Q4 2021 Report – ResearchAndMarkets.com financialbuzz.com ... Cell-Free DNA? Exosomes? Find out about the technology in readily understood terms that explain the jargon. Find the opportunities and pitfalls. Understand growth expectations and the ultimate potential market size.A revolution in cancer diagnostics is occurring using in vitro blood testing to identify cancer DNA. The technology has created the possibility of widespread screening for all types of cancers with a blood test.GRAIL, a new company with ...
10/11/2021 Ovarian Cancer Diagnostics Market Downstream Industries Analysis 2019-2025 packagingnews24.com Ovarian Cancer Diagnostics Market Downstream Industries Analysis 2019-2025 “”” The analysis and research team at Fact.MR enables customization of report for any market study. Our experienced research analysts will understand your exact business requirement and provide the most pertinent report for competitive gains. Overview The market intelligence report from Fact.MR is a valuable tool that enables vendors to identify growth avenues, and strategize for launch of products and ...